Thus, the biology of erlin2 underlies a really complex molecular scenario, implying that the alterations of different pathways can concur to the HSP’s pathogenesis on one side; to the other, it may also explain the clinical heterogeneity. Here, ERLIN2 is linked to hereditary spastic paraplegia.